Potassium Supplementation in CKD

Learn more about:
Related Clinical Trial
Patiromer Trial in CKD Stage IIIB to V Continuing Sodium Zirconium Cyclosilicate (SZC) After Discharge Study Description of the Clinical Outcomes of Hospitalized Patients With Heart Failure With Different Serum Potassium Levels Levalbuterol Compared to Albuterol Regarding Cardiac Side Effects and Potassium Lowering Effects. Artificial Intelligence-enable Electrocardiogram for Diagnosis and Outcome in Dyskalemia Effect of Sodium Zirconium Cyclosilicate on Arrythmia-related Cardiovascular Outcomes in Participants on Chronic Hemodialysis With Recurrent Hyperkalemia (DIALIZE-Outcomes) A Study to Investigate the Safety and Efficacy of ZS in Patients With Hyperkalemia. Hypomagnesemia Associated With Proton-Pump Inhibitor Use Open-label Safety of Sodium Zirconium Cyclosilicate for up to 12 Months in Japanese Subjects With Hyperkalemia The Effects of Patiromer on Serum Potassium Level and Gut Microbiome of ESRD Patients With Hyperkalemia A Study in Children With Hyperkalaemia Between Birth and Efficacy of Sodium Polystyrene Sulfonate in the Treatment of Hyperkaliemia in Pre-dialysis Patients Potassium Supplementation in CKD Cicletanine in Hypertension With Diabetes: Added Magnesium Preserves Potassium and Sodium Intravenous Fluids in Hospitalised Children Safety of Continuous Potassium Chloride Infusion in Critical Care Comparison of Dexmedetomidine and Remifentanil Infusion During CABG The Impact of Neut During Potassium Chloride Replacement on Pain and Incidence of Phlebitis Efficacy of KCl Plus 0.9%NaCl Compare With KCl Plus 0.45%NaCl Effect of Licorice and Hydrochlorothiazide on Plasma Potassium

Recruitment Information


Administrative Informations